• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SenesTech to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

    8/1/24 4:15:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials
    Get the next $SNES alert in real time by email

    Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET

    PHOENIX, Aug. 1, 2024 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES) will report financial results for its second quarter 2024, ended June 30, 2024, after the market close on Thursday, August 8, 2024. The Company has scheduled a conference call that same day, Thursday, August 8, 2024, at 5:00 pm ET, to review the results.

    SenesTech, Inc. has developed and is in the process of commercializing a proprietary technology for managing animal pest populations, primarily rat populations, through fertility control. (PRNewsfoto/SenesTech, Inc.)

    Second Quarter 2024 Conference Call Details

    Date and Time: Thursday, August 8, 2024, at 5:00 pm ET

    Call-in Information: Interested parties can access the conference call by dialing (844) 308-3351 or (412) 317-5407.

    Live Webcast Information: Interested parties can access the conference call via a live webcast, which is available in the Investor Relations section of the Company's website at https://app.webinar.net/e8OG9ey9o65 or http://senestech.investorroom.com/.

    Replay: A teleconference replay of the call will be available for seven days at (877) 344-7529 or (412) 317-0088, replay access code 6578863. A webcast replay will be available in the Investor Relations section of the Company's website at http://senestech.investorroom.com/ for 90 days. 

    About SenesTech

    We are committed to improving the health of the world by humanely managing animal pest populations through our expertise in fertility control. We invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, as well as Evolve and Evolve Mouse, EPA-designated minimum risk contraceptives for rodents, reflecting our mission to provide products that are proactive, safe and sustainable. ContraPest and Evolve fit seamlessly into all integrated pest management programs, significantly improving the overall goal of effective pest management. We strive for clean cities, efficient businesses and happy households – with a product designed to be humane, effective and sustainable.

    For more information visit https://senestech.com/.

    Safe Harbor Statement 

    This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby.  Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases.  You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements.  Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; our ability to regain and maintain compliance with Nasdaq's continued listing requirements; and regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023.  All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date.  Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.

    CONTACT: 

    Investor: Robert Blum, Lytham Partners, LLC, 602-889-9700, [email protected]

    Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-to-report-second-quarter-2024-financial-results-on-thursday-august-8-2024-302211544.html

    SOURCE SenesTech, Inc.

    Get the next $SNES alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SNES

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SNES
    SEC Filings

    View All

    SEC Form EFFECT filed by SenesTech Inc.

    EFFECT - SenesTech, Inc. (0001680378) (Filer)

    8/25/25 12:15:30 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form 424B3 filed by SenesTech Inc.

    424B3 - SenesTech, Inc. (0001680378) (Filer)

    8/22/25 4:16:35 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form S-3 filed by SenesTech Inc.

    S-3 - SenesTech, Inc. (0001680378) (Filer)

    8/15/25 4:24:01 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Graham Lynn Yako claimed no ownership of stock in the company (SEC Form 3)

    3 - SenesTech, Inc. (0001680378) (Issuer)

    8/14/25 5:09:06 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form 4 filed by Director Moss Joshua Matthew

    4 - SenesTech, Inc. (0001680378) (Issuer)

    1/10/25 4:44:49 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    New insider Moss Joshua Matthew claimed no ownership of stock in the company (SEC Form 3)

    3 - SenesTech, Inc. (0001680378) (Issuer)

    1/10/25 4:41:13 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Leadership Updates

    Live Leadership Updates

    View All

    SenesTech Names Nicole Williams as Chief Revenue Officer

    PHOENIX, Feb. 16, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the appointment of Nicole Williams as Chief Revenue Officer. Ms. Williams was previously Chief Strategy Officer, and this appointment is part of an expansion and restructuring of the sales organization and commercialization efforts. The restructuring of the team comes after yet another quarter and fiscal ye

    2/16/23 9:00:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces Appointment of Vector and Pest Control Industry Veteran Joel Fruendt as Chief Executive Officer

    PHOENIX, Nov. 14, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", ))), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the appointment of Joel Fruendt as SenesTech's new Chief Executive Officer, succeeding Ken Siegel. Mr. Siegel, who is expected to retire at the end of the year, will remain as an Executive Director, in a consultative role, through the transition period. This leadership transition is part of SenesTech's ongoing strategic plan to drive the commercialization of ContraPest, its flagship product.

    11/14/22 9:10:00 AM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Financials

    Live finance-specific insights

    View All

    SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins

    94% Revenue Growth in Evolve™ Rodent Birth Control Products Strong Cash Balance and Sustained Progress Toward Profitability SURPRISE, Ariz., Aug. 7, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the second quarter ended June 30, 2025. Q2 2025 Highlights Revenues increased 36% to $625,000, a record for the Company, from $459,000 in Q2 2024.Evolve Rodent Birth Control products sales grew 94%

    8/7/25 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

    Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern time PHOENIX, July 31, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in fertility control for managing animal pest populations, will report second quarter 2025 financial results for the period ended June 30, 2025, after the market close on Thursday, August 7, 2025. The Company has scheduled a conference call that same day, Thursday, August 7, 2025, at 5:00 p.m. Eastern time, to review the results. Second Quarter 2025 Conference Call Details Date and Time: Th

    7/31/25 4:15:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Reports First Quarter 2025 Financial Results 40% Revenue Growth in Evolve™, Record Gross Profit Margins of 65%, and Continued Progress Toward Profitability

    SURPRISE, Ariz., May 8, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the first quarter ended March 31, 2024. Q1 2025 Highlights Revenues increased 17% to $485,000 from $415,000 in Q1 2024.Evolve product sales grew 40% year-over-year, now representing 79% of total revenue.Gross profit margin expanded to 64.5%, a record for the Company, compared to 32.5% in Q1 2024.Net loss for Q1 2025 was

    5/8/25 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:28:08 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by SenesTech Inc.

    SC 13G/A - SenesTech, Inc. (0001680378) (Subject)

    11/14/24 7:12:23 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form SC 13G filed by SenesTech Inc.

    SC 13G - SenesTech, Inc. (0001680378) (Subject)

    11/12/24 4:30:48 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $SNES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    SenesTech to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025

    SURPRISE, Ariz., Aug. 18, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcast presentation at the Lytham Partners 2025 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 19, 2025. The webcast will take place at 3:30 p.m. ET on Tuesday, August 19, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/cts2025/ or directly at https://lythampartners.com/cts2025/snes. A replay will also

    8/18/25 4:15:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins

    94% Revenue Growth in Evolve™ Rodent Birth Control Products Strong Cash Balance and Sustained Progress Toward Profitability SURPRISE, Ariz., Aug. 7, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-registered rodent birth control products today announced its financial results for the second quarter ended June 30, 2025. Q2 2025 Highlights Revenues increased 36% to $625,000, a record for the Company, from $459,000 in Q2 2024.Evolve Rodent Birth Control products sales grew 94%

    8/7/25 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SenesTech Announces Closing of Warrant Exercise for $6.3 Million in Gross Proceeds

    SURPRISE, Ariz., Aug. 5, 2025 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES, ", SenesTech", or the ", Company", )), a leader in fertility control for managing animal pest populations, announced today the closing of its previously announced exercise of certain outstanding warrants to purchase an aggregate of 1,458,872 shares of the Company's common stock originally issued by the Company on July 1, 2025, at the existing exercise price of $4.15 per share. H.C. Wainwright acted as the exclusive placement agent for the transaction. As consideration for the exercise of such existing

    8/5/25 7:10:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials